MORROW launches Singapore flagship, targets $230 million yearly revenue

MORROW opened a 45,000‑sq‑ft flagship in Singapore’s Longevity World mall, presenting its first proof point for a globally scalable preventive‑healthcare model. The centre combines clinical diagnostics, doctor‑led guidance and personalised health planning with movement, nutrition, recovery and coaching services.

Backed by US$156 million in committed investment, MORROW plans to roll out more than ten locations across Asia, Australasia and the Middle East within five years, aiming for over US$230 million in annual revenue. Founder and CEO Allen Law said the shift toward prevention is an economic necessity, noting that scaling proven preventive interventions could generate US$12.5 trillion in annual value by 2050. The Singapore flagship is intended to serve as a blueprint for making preventive healthcare accessible worldwide.